Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial...

Area of Science:

• Biomolecular Engineering
• Cardiovascular Research
• Bioinformatics

Background:

• ST-elevation Myocardial Infarction (STEMI) and Non-ST-elevation Myocardial Infarction (NSTEMI) are critical cardiovascular events often stemming from coronary artery stenosis.
• Gene biomarkers are crucial for accurate clinical diagnosis and guiding therapeutic strategies in Myocardial Infarction (MI).
• Distinguishing between STEMI and NSTEMI at a molecular level is essential for personalized patient management.

Purpose of the Study:

• To develop and validate timely blood gene profiles for the molecular differentiation of STEMI and NSTEMI.
• To leverage high-throughput data and bioinformatics tools for identifying key gene signatures.
• To establish temporal cut-off points for these gene profiles in relation to MI onset.

Main Methods:

• Integration of text mining, DisGeNET, and Gene Expression Omnibus (GEO) datasets using R software.
• Construction and refinement of STEMI and NSTEMI gene networks using STRING and Cytoscape.
• Enrichment analysis of high-score genes via KEGG signaling pathways and Gene Ontology (GO).
• Statistical identification of time cut-off points for gene profile changes post-MI.

Main Results:

• Development of distinct gene profiles for STEMI and NSTEMI through network and enrichment analyses.
• Identification of specific gene sets differentiating STEMI (69 high-fold, 45 low-fold) and NSTEMI (68 high-fold, 36 low-fold).
• Establishment of statistically significant time cut-off points: 4 genes for NSTEMI and 13 genes for STEMI within three days post-MI.
• Demonstration of differing biological conditions and pathophysiologies between STEMI and NSTEMI.

Conclusions:

• The study successfully established distinct, time-sensitive blood gene profiles for differentiating STEMI and NSTEMI.
• The identified gene profiles and their temporal dynamics offer valuable insights into the distinct pathophysiological mechanisms of STEMI and NSTEMI.
• These molecular signatures, particularly those identified within three days of MI, hold promise for improved diagnostic accuracy and targeted treatment strategies.